N. Caplen

发表

Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process.

P. Hayes, E. Kinrade, X. Gao, 1994, Gene therapy.

CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium.

N. Caplen, D. Geddes, T. Pitt, 1996, American journal of respiratory cell and molecular biology.

The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro

E. Alton, F. Sorgi, L. Huang, 1998, Gene Therapy.

Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects.

E. Alton, F. Sorgi, L. Huang, 1995, Gene therapy.

New treatments for cystic fibrosis.

D. Geddes, E. Alton, N. Caplen, 1992, British medical bulletin.

In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE.

N. Caplen, D. Geddes, E. Kinrade, 1995, Gene therapy.

Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth.

E. Alton, L. Huang, X. Gao, 1994, The European respiratory journal.

Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans.

D. Porteous, D. Geddes, E. Alton, 1995, The American journal of physiology.

Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

A. Miller, S. Hart, E. Alton, 1993 .

The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro

E. Alton, F. Sorgi, D. Gruenert, 1998, Gene Therapy.

Gene therapy for cystic fibrosis.

C. Coutelle, C. Huxley, S. Hart, 1993, Archives of disease in childhood.

Corrigendum: Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

S. Hart, E. Alton, P. Jeffery, 1993, Nature Genetics.